Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis

BACKGROUND AND AIMS: Cumulative safety and tolerability of budesonide MMX, a once-daily oral corticosteroid for inducing mild to moderate ulcerative colitis remission, was examined. METHODS: Data from three randomized, double-blind, placebo-controlled, phase II or III studies [budesonide MMX 9mg, 6m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtenstein, Gary R., Travis, Simon, Danese, Silvio, D’Haens, Geert, Moro, Luigi, Jones, Richard, Huang, Michael, Ballard, E. David, Bagin, Robert, Hardiman, Yun, Collazo, Raul, Sandborn, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736820/
https://www.ncbi.nlm.nih.gov/pubmed/26094251
http://dx.doi.org/10.1093/ecco-jcc/jjv101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736820/
https://www.ncbi.nlm.nih.gov/pubmed/26094251
http://dx.doi.org/10.1093/ecco-jcc/jjv101

Ejemplares similares